NAS:RPID (USA)
Â
Class A
$
1.3
-0.075 (-5.42%)
10:08 PM EST
Business Description
Rapid Micro Biosystems Inc
NAICS : 423450
SIC : 5047
ISIN : US75340L1044
Share Class Description:
RPID: Class ATotal Employee Number:
171Description
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.84 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.32 | |||||
Debt-to-EBITDA | -0.51 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -13.78 | |||||
Beneish M-Score | -3.73 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23 | |||||
3-Year EBITDA Growth Rate | 12.4 | |||||
3-Year EPS without NRI Growth Rate | 9.8 | |||||
3-Year FCF Growth Rate | 22.6 | |||||
3-Year Book Growth Rate | -42.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 30.25 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 24.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 5.8 | |||||
9-Day RSI | 14.44 | |||||
14-Day RSI | 21.68 | |||||
3-1 Month Momentum % | 3.52 | |||||
6-1 Month Momentum % | -52.75 | |||||
12-1 Month Momentum % | -15.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.55 | |||||
Quick Ratio | 1.51 | |||||
Cash Ratio | 1.09 | |||||
Days Inventory | 210.02 | |||||
Days Sales Outstanding | 54.98 | |||||
Days Payable | 45.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | -27.26 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 5.55 | |||||
Operating Margin % | -141.45 | |||||
Net Margin % | -145.55 | |||||
EBITDA Margin % | -130.2 | |||||
FCF Margin % | -114.83 | |||||
OCF Margin % | -113.88 | |||||
ROE % | -150.39 | |||||
ROA % | -71.98 | |||||
ROIC % | -148.73 | |||||
3-Year ROIIC % | -35.23 | |||||
ROC (Joel Greenblatt) % | -208.84 | |||||
ROCE % | -91.35 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.69 | |||||
PB Ratio | 3.66 | |||||
Price-to-Tangible-Book | 3.61 | |||||
EV-to-EBIT | -1.41 | |||||
EV-to-EBITDA | -1.5 | |||||
EV-to-Revenue | 1.96 | |||||
EV-to-Forward-Revenue | 6.19 | |||||
EV-to-FCF | -1.71 | |||||
Price-to-GF-Value | 0.68 | |||||
| Price-to-Net-Current-Asset-Value | 11.82 | |||||
Earnings Yield (Greenblatt) % | -70.92 | |||||
FCF Yield % | -61.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RPID
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rapid Micro Biosystems Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 35.176 | ||
| EPS (TTM) ($) | -1.12 | ||
| Beta | 0.974 | ||
| 3-Year Sharpe Ratio | 0.65 | ||
| 3-Year Sortino Ratio | 1.36 | ||
| Volatility % | 109.77 | ||
| 14-Day RSI | 21.68 | ||
| 14-Day ATR ($) | 0.121484 | ||
| 20-Day SMA ($) | 1.5945 | ||
| 12-1 Month Momentum % | -15.57 | ||
| 52-Week Range ($) | 1.29 - 4.94 | ||
| Shares Outstanding (Mil) | 50.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rapid Micro Biosystems Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rapid Micro Biosystems Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 08:30 | In 63 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 62 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 08:30 | 2.08 (-0.95%) | ||
| Second quarter earnings results for 2026 | 2026-08-07 | 2.08 (-0.95%) | ||
| General meeting for 2026 | 2026-05-21 09:00 | 2.01 (+0.50%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 16:30 | 2.58 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 2.58 (+0.00%) | ||
| the KeyBanc Capital Markets Healthcare Forum | 2026-03-17 11:15 | 2.97 (+2.06%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-12 08:30 | 4.38 (+5.54%) | ||
| Annual report for 2025 | 2026-03-12 | 4.38 (+5.54%) |
Show
Entries
Rapid Micro Biosystems Inc Frequently Asked Questions
What is Rapid Micro Biosystems Inc(RPID)'s stock price today?
The current price of RPID is $1.30. The 52 week high of RPID is $4.94 and 52 week low is $1.29.
When is next earnings date of Rapid Micro Biosystems Inc(RPID)?
The next earnings date of Rapid Micro Biosystems Inc(RPID) is 2026-11-06 Est..
Does Rapid Micro Biosystems Inc(RPID) pay dividends? If so, how much?
Rapid Micro Biosystems Inc(RPID) does not pay dividend.
Guru Commentaries on NAS:RPID
Hazelton Capital Partners
Bullish
2026 Q1
wbc letter 2026 q1
What the manager wrote
Rapid Micro Biosystems ($RPID) also continues to be an extremely favorable risk reward. We believe guidance to be conservative given increasing business momentum with significant early rollouts with Amgen, Samsung Biologics, and Merck Millipore - all of which have capacity and are likely to place large follow-on orders. We also believe the company has good line of sight to increased gross margin upside starting in 2Q’26 when their new vendor agreements kick in. We believe management is exceptionally conservative, the company is well positioned, and the company represents the best risk reward in the portfolio.
Press Release
Articles on Rapid Micro Biosystems Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers